Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
-
Vivos Announces Collaboration Agreement with Florida Cardiology Group to Extend Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
-
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
-
Vivos Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
-
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
-
Vivos Therapeutics Reports Full Year 2025 Financial Results Full Year 2025 revenue increased 16%
-
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
-
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
-
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare
-
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy